PackTalk is a blog for the Healthcare Packaging Industry

Clinical Trials in Europe Show Promise for Treatment of COVID-19


Published on April 17, 2020

Roche Phase III Covid-19 clinical trial is under way, as United Kingdom Prime Minister Boris Johnson continues his recovery from the novel coronavirus.

As the UK responds to high numbers and their own PM’s brush with death from Covid-19, it is clear no greater need exists than to see approval of life-saving treatments available to the worldwide market. Roche continues to be a major player as the pharmaceutical industry works with global regulatory leaders in the fight against the pandemic.

In March, Pharma Times reported that Roche was approved (with French partner Sanofi, Eusa Pharma and US-based Regeneron) to undertake a Phase III clinical trial (COVACTA). Enrollment of 330 patients from across the world began in early April, with six patients enrolled to date from Spain and the US. Eligible patients must be hospitalized with “severe” Covid-19 pneumonia to be considered for the FDA-backed trial.

Actemra/RoActemra has previously been claimed as part of China’s Covid-19 treatment plan, published by the NHC on March 3, 2020. Existing independent studies for the drug’s use with Covid-19 patients offer limited published findings, such as a three-patient report of major improvement from a Naples, Italy hospital that was then tried at other Italian hospitals. This will be the first well-controlled, global study to clinically examine safety and efficacy. The trial paves the way to confirm or disprove Actemra/RoActemra as a viable treatment for patients suffering serious cases of Covid-19.

Read more here:

 


Comments (0)

Related Articles

Cold Chain Packaging: Packaging Engineers Wanted

July 30, 2021

COVID-19 has put a public spotlight on the economic global demands and challenges related to cold chain drug supply and delivery. And while the growth trends in the world of cold chain packaging are not new, the focus is certainly heightened, leading...

Learn More

How Particulate Control Can Save or Destroy Your Next Launch

July 30, 2021

In the midst of a pandemic raging across the world, pharmaceutical companies are more and more alerted to the dangers and risks of drug product contamination. The recent FDA-ordered destruction of 60 million vaccine doses is one very prominent example. One...

Learn More

The Next Decade of Medical Packaging Belongs to China  – Part 3

July 30, 2021

The final part of our three-part series examines China’s role in the global supply chain for medical devices and packaging. A strong central government and experience managing pandemics led the country to a rapid rebound ahead of other economies.

Part 3:...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.